Genomics

Dataset Information

0

Development of next-generation therapeutic antibodies using rapid mRNA immunization of humanized mice

ABSTRACT: Development of next-generation therapeutic antibodies using rapid mRNA immunization of humanized mice

PROVIDER: PRJNA890315 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR21898861_1.fastq.gz Fastqsanger.gz
SRR21898861_2.fastq.gz Fastqsanger.gz
SRR21898862_1.fastq.gz Fastqsanger.gz
SRR21898862_2.fastq.gz Fastqsanger.gz
SRR21898863_1.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 14

Similar Datasets

Transcriptomics Development of next-generation therapeutic antibodies using rapid mRNA immunization of humanized mice
2023-10-01 | GSE215441 | GEO
Proteomics Overcoming steric restrictions of VRC01 HIV-1 neutralizing antibodies through immunization
2020-05-26 | PXD015168 | Pride
Genomics Therapeutic antibodies to ganglioside GD2 evolved from highly selective germline antibodies
| PRJNA391729 | ENA
Genomics Therapeutic antibodies to ganglioside GD2 evolved from highly selective germline antibodies II
| PRJNA391734 | ENA
Genomics Therapeutic antibodies to ganglioside GD2 evolved from highly selective germline antibodies I
| PRJNA391733 | ENA
Genomics Therapeutic antibodies to ganglioside GD2 evolved from highly selective germline antibodies III
| PRJNA391735 | ENA
Genomics Therapeutic antibodies to ganglioside GD2 evolved from highly selective germline antibodies IV
| PRJNA391736 | ENA
Genomics Therapeutic antibodies to ganglioside GD2 evolved from highly selective germline antibodies V
| PRJNA391737 | ENA
Genomics Therapeutic antibodies to ganglioside GD2 evolved from highly selective germline antibodies VI
| PRJNA391738 | ENA
Genomics Developing & Optimizing Acute Myeloid Leukemia Specific Therapeutic Antibodies
| PRJNA909822 | ENA